- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
B
BMEA
Biomea Fusion, Inc.
1.28
-0.04-3.03%After Hours: 1.280 0.00 0.00%19:53 02/23 EST
OPEN/PREV CLOSE1.340/1.320
TODAY RANGE1.250-1.340
VOL495.09K
MARKET CAP90.50M
52 WEEK RANGE0.8719-3.500
AVG VOL (3M)1.26M
% TURNOVER0.70%
TURNOVER--
P/E (TTM)-0.5352
% RANGE6.82%
EPS(TTM)-2.3915
P/E(FORWARD)-0.7943
P/B4.876
BVPS0.2625
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP83.26M
SHARES OUTSTANDING70.70M
NEXT EARNINGS03/31-04/13
FREE FLOAT65.05M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·01/23 16:24
JPMorgan’s top short ideas for Q1: FTNT, TXT, IMO and more
TipRanks·01/14 21:37
Biomea Fusion Highlights Diabetes Pipeline at JPM Conference
TipRanks·01/13 20:20
Biomea Fusion initiated with a Buy at Rodman & Renshaw
Dow Jones·01/13 12:49
Biomea Fusion Is Maintained at Buy by D. Boral Capital
Dow Jones·01/13 12:49
Biomea Fusion Price Target Maintained With a $12.00/Share by D. Boral Capital
Benzinga·01/13 12:38
D. Boral Capital Maintains Buy on Biomea Fusion, Maintains $12 Price Target
TipRanks·01/13 11:48
H.C. Wainwright Sticks to Its Buy Rating for Biomea Fusion (BMEA)
TipRanks·01/12 13:40
Biomea Fusion enters 2026 focused on icovamenib, BMF-650 milestones
Reuters·12/17/2025 12:00
Biomea Fusion to Present at J.P. Morgan Healthcare Conference
TipRanks·12/16/2025 02:10
Top Executive Makes Bold Move with Major Stock Purchase in Biomea Fusion
Reuters·12/15/2025 21:15
Director and Officer Rainer M. Erdtmann Acquires Common Shares of Biomea Fusion Inc
Simply Wall St·12/11/2025 10:41
Interim CEO & Director of Biomea Fusion Michael J. Hitchcock Buys 667% More Shares
Same Industry
Name/Symbol
Change%
Price